- Home
- DRDB vs LUNG Comparison
DRDB vs LUNG Comparison
Compare DRDB & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRDB
- LUNG
- Stock Information
- Founded
- DRDB 2024
- LUNG 1995
- Country
- DRDB United States
- LUNG United States
- Employees
- DRDB N/A
- LUNG N/A
- Industry
- DRDB
- LUNG Industrial Specialties
- Sector
- DRDB
- LUNG Health Care
- Exchange
- DRDB Nasdaq
- LUNG Nasdaq
- Market Cap
- DRDB 305.1M
- LUNG 299.3M
- IPO Year
- DRDB 2024
- LUNG 2020
- Fundamental
- Price
- DRDB $10.04
- LUNG $6.82
- Analyst Decision
- DRDB
- LUNG Strong Buy
- Analyst Count
- DRDB 0
- LUNG 7
- Target Price
- DRDB N/A
- LUNG $12.64
- AVG Volume (30 Days)
- DRDB 102.9K
- LUNG 253.9K
- Earning Date
- DRDB 01-01-0001
- LUNG 04-30-2025
- Dividend Yield
- DRDB N/A
- LUNG N/A
- EPS Growth
- DRDB N/A
- LUNG N/A
- EPS
- DRDB N/A
- LUNG N/A
- Revenue
- DRDB N/A
- LUNG $83,789,000.00
- Revenue This Year
- DRDB N/A
- LUNG $17.96
- Revenue Next Year
- DRDB N/A
- LUNG $18.35
- P/E Ratio
- DRDB N/A
- LUNG N/A
- Revenue Growth
- DRDB N/A
- LUNG 22.01
- 52 Week Low
- DRDB $9.87
- LUNG $5.46
- 52 Week High
- DRDB $10.04
- LUNG $10.01
- Technical
- Relative Strength Index (RSI)
- DRDB N/A
- LUNG 40.98
- Support Level
- DRDB N/A
- LUNG $7.65
- Resistance Level
- DRDB N/A
- LUNG $7.97
- Average True Range (ATR)
- DRDB 0.00
- LUNG 0.46
- MACD
- DRDB 0.00
- LUNG -0.14
- Stochastic Oscillator
- DRDB 0.00
- LUNG 21.21
About DRDB Roman DBDR Acquisition Corp. II Ordinary shares
Roman DBDR Acquisition Corp II is a blank check company.
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.